FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company), a leading global medical technology company, announced a major milestone for the In Celebration of Her™ program. Since its launch in 2014,… Read More
FRANKLIN LAKES, N.J. BD (Becton, Dickinson and Company) , a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic… Read More
The Ontario Government has announced more details on the long-awaited cancer therapies pilot dubbed the Funding Accelerated for Specific Treatments (FAST) program. It promises to allow the fast-tracking of access to… Read More
JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended receptor occupancy with the goal of delivering deeper, more durable B cell depletion with less… Read More
Patients treated with subcutaneous TREMFYA® achieved clinically meaningful results in both clinical remission (36.7%) and endoscopic remission (25.9%) at Week 48 in the Phase 3 ASTRO study Clinical and endoscopic outcomes… Read More
